Oral semaglutide was approved by the FDA in December 2025 as a once-daily pill (25 mg), intended to limit excess body weight ...

Upslope Capital Management, an investment management company, released its fourth-quarter 2025 investor letter. A copy of the ...

TOKYO, JAPAN, January 14, 2026 / EINPresswire.com / — LOTTE Holdings, Co., Ltd. (Tokyo, Japan; CEO: Genichi Tamatsuka, hereinafter “LOTTE Holdings”) announces an investment in OmicInsight Corporation ...

Rounding up five deals in the pharma commercialization segment, and delving into trends driving that activity; a discussion ...

During Q4, ClearBridge International Growth EAFE Strategy underperformed its MSCI EAFE Index benchmark and MSCI EAFE Growth ...

Johnson & Johnson unveils US$4bn build programme for pharmaceutical manufacturing in Pennsylvania and North Carolina ...

Culminate H Labs Co-Founders Calixto Vallejo, and Juan Carlos Rodriguez are elevating human potential through science—showing ...

Pediatric-onset IBD is characterized by increasing incidence and prevalence, a comprehensive diagnostic workup, an extensive inflammatory phenotype compared to adult patients, and a risk of ...

Turning Any Medication into a Precision AI-Combo Drug through Simple QR-Code Integration LAS VEGAS, NV / ACCESS ...

Anthropic has launched Claude for Healthcare, a HIPAA-ready AI platform for hospitals and pharmaceutical companies, days ...

Antibiotic factories release resistance genes at levels 100x higher than city sewage. Pharmaceutical pollution is fueling ...